CA2570570A1 - Compositions et procedes pour la codelivrance de medicaments anticancereux, de medicaments anti-angiogeniques, et d'un polysaccharide - Google Patents
Compositions et procedes pour la codelivrance de medicaments anticancereux, de medicaments anti-angiogeniques, et d'un polysaccharide Download PDFInfo
- Publication number
- CA2570570A1 CA2570570A1 CA002570570A CA2570570A CA2570570A1 CA 2570570 A1 CA2570570 A1 CA 2570570A1 CA 002570570 A CA002570570 A CA 002570570A CA 2570570 A CA2570570 A CA 2570570A CA 2570570 A1 CA2570570 A1 CA 2570570A1
- Authority
- CA
- Canada
- Prior art keywords
- polysaccharide
- composition
- cancer
- backbone
- carbohydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58195804P | 2004-06-22 | 2004-06-22 | |
US60/581,958 | 2004-06-22 | ||
PCT/US2005/021827 WO2006002106A2 (fr) | 2004-06-22 | 2005-06-21 | Compositions et procedes pour la codelivrance de medicaments anticancereux, de medicaments anti-angiogeniques, et d'un polysaccharide |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2570570A1 true CA2570570A1 (fr) | 2006-01-05 |
Family
ID=35782284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002570570A Abandoned CA2570570A1 (fr) | 2004-06-22 | 2005-06-21 | Compositions et procedes pour la codelivrance de medicaments anticancereux, de medicaments anti-angiogeniques, et d'un polysaccharide |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1765365A4 (fr) |
JP (1) | JP2008503583A (fr) |
CN (1) | CN101267828A (fr) |
BR (1) | BRPI0512394A (fr) |
CA (1) | CA2570570A1 (fr) |
WO (1) | WO2006002106A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2303311B1 (fr) | 2008-05-14 | 2018-08-01 | Agriculture Victoria Services Pty Ltd | L'angiogénine pour l'utilisation pour traiter des maladies des muscles squelettiques |
AU2013204721B2 (en) * | 2008-05-14 | 2016-08-18 | Agriculture Victoria Services Pty Ltd | Methods for treating cachexia |
CZ302789B6 (cs) | 2009-11-25 | 2011-11-09 | Zentiva, K. S. | Zpusob zvýšení rozpustnosti farmaceuticky aktivních látek a cílený (kontrolovaný) transport do streva |
AU2013204740C1 (en) * | 2012-05-10 | 2015-10-01 | Agriculture Victoria Services Pty Ltd | Methods of treating cancer using angiogenin or an angiogenin agonist |
FR3022462B1 (fr) * | 2014-06-18 | 2018-04-27 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Composition orale d'anticorps anti-tnfalpha |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5308838A (en) * | 1982-05-07 | 1994-05-03 | Carrington Laboratories, Inc. | Uses of aloe products |
CA1340994C (fr) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Traitement de maladies et d'etats pathologiques |
US20020107222A1 (en) * | 1993-03-01 | 2002-08-08 | David Platt | Modified polysaccharides for treatment of cancer |
US5834442A (en) * | 1994-07-07 | 1998-11-10 | Barbara Ann Karmanos Cancer Institute | Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
EP0958825A1 (fr) * | 1998-05-18 | 1999-11-24 | Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) | Composition synergique à activité anticancéreuse à base de carbohydrates non digestibles et d'un médicament anti-cancéreux |
JP2003508468A (ja) * | 1999-09-06 | 2003-03-04 | バイゼル ギュンター | 長時間持続性の満腹効果を得るための架橋された薬剤及びその製法 |
US7012068B2 (en) * | 2001-03-27 | 2006-03-14 | Pro-Pharmaceuticals, Inc. | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
KR20040045795A (ko) * | 2002-11-25 | 2004-06-02 | 주식회사한국신약 | 펠리누스 린테우스에서 추출한 다당류와 마이토마이신c를 포함하는 복합 항암제 |
-
2005
- 2005-06-21 CA CA002570570A patent/CA2570570A1/fr not_active Abandoned
- 2005-06-21 EP EP05786102A patent/EP1765365A4/fr not_active Withdrawn
- 2005-06-21 BR BRPI0512394-1A patent/BRPI0512394A/pt not_active IP Right Cessation
- 2005-06-21 CN CNA2005800207078A patent/CN101267828A/zh active Pending
- 2005-06-21 JP JP2007518186A patent/JP2008503583A/ja active Pending
- 2005-06-21 WO PCT/US2005/021827 patent/WO2006002106A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2008503583A (ja) | 2008-02-07 |
BRPI0512394A (pt) | 2008-03-11 |
WO2006002106A3 (fr) | 2006-10-19 |
CN101267828A (zh) | 2008-09-17 |
EP1765365A2 (fr) | 2007-03-28 |
WO2006002106A2 (fr) | 2006-01-05 |
EP1765365A4 (fr) | 2008-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101561860B1 (ko) | 비항응고성 다당류 조성물 | |
EP0768885B1 (fr) | Procede d'inhibition de la metastase cancereuse par administration orale d'une pectine soluble modifiee du citrus | |
ITRM20000041A1 (it) | Derivati glicosamminoglicani parzialmente desolfatati non anticoagulanti ad attivita' antiangiogenica. | |
BG66191B1 (bg) | Полизахариди с антитромболитична активност, които съдържат поне една ковалентна връзка с биотин или производно на биотин | |
US11628183B2 (en) | Highly purified fucans for the treatment of fibrous adhesions | |
CA2570570A1 (fr) | Compositions et procedes pour la codelivrance de medicaments anticancereux, de medicaments anti-angiogeniques, et d'un polysaccharide | |
US11938226B2 (en) | Abiotic anti-VEGF nanoparticle | |
US20070258969A1 (en) | Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers | |
US9572831B2 (en) | Composition and method for sulfated non-anticoagulant low molecular weight heparins in cancer and tumor metastasis | |
US9387256B2 (en) | Tissue targeting | |
US20020107222A1 (en) | Modified polysaccharides for treatment of cancer | |
ES2458818T3 (es) | Métodos para evaluar la actividad de una composición de polisacárido | |
US20050282773A1 (en) | Modified polysaccharides in combination with anti-cancer drugs for enhanced treatment of cancer | |
JP6444399B2 (ja) | 癌の処置に用いるための硫酸化多糖 | |
Yang et al. | End-functionalised glycopolymers as glycosaminoglycan mimetics inhibit HeLa cell proliferation | |
Cai et al. | Multifunctionalized brush-like glycopolymers with high affinity to P-selectin and antitumor metastasis activity | |
WO2004064777A2 (fr) | Polysaccharides modifies associes a des medicaments anticancereux pour accroitre l'efficacite d'un traitement contre le cancer | |
파자나 | Designing functional formulations of a taurocholate conjugated low molecular weight heparin derivative for targeting tumor angiogenesis and metastasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |